BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 170110)

  • 1. Synthetic inhibitors of adenylate kinases in the assays for ATPases and phosphokinases.
    Feldhau P; Fröhlich T; Goody RS; Isakov M; Schirmer RH
    Eur J Biochem; 1975 Sep; 57(1):197-204. PubMed ID: 170110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P1,P5-Di(adenosine-5')pentaphosphate(Ap5A) as an inhibitor of adenylate kinase in studies of fragmented sarcoplasmic reticulum from bullfrog skeletal muscle.
    Kurebayashi N; Kodama T; Ogawa Y
    J Biochem; 1980 Sep; 88(3):871-6. PubMed ID: 6252207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle adenylate kinase in Duchenne muscular dystrophy.
    Fröhlich T; Reitter B; Scheffner D; Schirmer RH; Untucht-Grau R
    Biochim Biophys Acta; 1986 Oct; 883(3):598-603. PubMed ID: 3019420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Elimination and excretion of adenylate kinases following cell damage].
    Sachsenheimer W; Goody RS; Schirmer RH
    Klin Wochenschr; 1975 Jul; 53(13):617-22. PubMed ID: 170450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of rabbit, pig, and carp adenylate kinases by N6-o- and p-fluorobenzoyladenosine 5'-triphosphates.
    Hampton A; Slotin LA
    Biochemistry; 1975 Dec; 14(25):5438-44. PubMed ID: 172123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of adenylate kinase by P1-(lin-benzo-5'-adenosyl)-P4-(5'-adenosyl) tetraphosphate and P1-(lin-benzo-5'-adenosyl)-P5-(5'-adenosyl pentaphosphate.
    VanDerLijn P; Barrio JR; Leonard NJ
    Biochemistry; 1979 Dec; 18(25):5557-61. PubMed ID: 229895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P1, P5-Bis-(5'-adenosyl)pentaphosphate: is this adenylate kinase inhibitor substrate for mitochondrial processes?
    Köhrle J; Lüstorff J; Schlimme E
    Z Naturforsch C Biosci; 1977; 32(9-10):786-91. PubMed ID: 201118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfur specifically inhibits adenylate kinase in assays for creatine kinase.
    Russell PJ; Conner J; Sisson S
    Clin Chem; 1984 Sep; 30(9):1555-7. PubMed ID: 6088119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creatine kinase in serum: 3. Further study of adenylate kinase inhibitors.
    Szasz G; Gerhardt W; Gruber W
    Clin Chem; 1977 Oct; 23(10):1888-92. PubMed ID: 198164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does an inhibitor of mitochondrial adenylate kinase also affect oxidative phosphorylation?
    Lüstorff J; Schlimme E
    Experientia; 1976 Mar; 32(3):298-9. PubMed ID: 176055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An aberrant adenylate kinase isoenzyme from the serum of patients with Duchenne muscular dystrophy.
    Hamada M; Okuda H; Oka K; Watanabe T; Ueda K; Nojima M; Kuby SA; Manship M; Tyler FH; Ziter FA
    Biochim Biophys Acta; 1981 Aug; 660(2):227-37. PubMed ID: 6269633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of carbamyl phosphate synthetase by P1, P5-di(adenosine 5')-pentaphosphate: evidence for two ATP binding sites.
    Powers SG; Griffith OW; Meister A
    J Biol Chem; 1977 May; 252(10):3558-60. PubMed ID: 193838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myokinase and contractile function of glycerinated muscle fibers.
    Savabi F; Geiger PJ; Bessman SP
    Biochem Med Metab Biol; 1986 Apr; 35(2):227-38. PubMed ID: 3011038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of adenylate kinase by P1,P5-di(adenosine 5') pentaphosphate in assays of erythrocyte enzyme activities requiring adenine nucleotides.
    Valentine WN; Paglia DE; Nakatani M; Brockway RA
    Am J Hematol; 1989 Oct; 32(2):143-5. PubMed ID: 2547314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The structural isomerisation of human-muscle adenylate kinase as studied by 1H-nuclear magnetic resonance.
    Kalbitzer HR; Marquetant R; Rösch P; Schirmer RH
    Eur J Biochem; 1982 Sep; 126(3):531-6. PubMed ID: 6291931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pivotal role of phosphate chain length in vasoconstrictor versus vasodilator actions of adenine dinucleotides in rat mesenteric arteries.
    Ralevic V; Hoyle CH; Burnstock G
    J Physiol; 1995 Mar; 483 ( Pt 3)(Pt 3):703-13. PubMed ID: 7776252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative inhibition of human adenylate kinase and creatine kinase isoenzymes by adenosine 5'-monophosphate and diadenosine pentaphosphate.
    Nealon DA
    Clin Chem; 1985 Feb; 31(2):333-4. PubMed ID: 2981647
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of adenine nucleotide derivatives to assess the potential of exo-active-site-directed reagents as species- or isozyme-specific enzyme inactivators. 4. Interactions of adenosine 5'-triphosphate derivatives with adenylate kinases from Escherichia coli and rat tissues.
    Hampton A; Picker D; Nealy KA; Maeda M
    J Med Chem; 1982 Apr; 25(4):382-6. PubMed ID: 6279845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A kinetic study of the photochemical inactivation of adenylate kinases of Mycobacterium marinum and bovine heart mitochondria.
    Batra PP; Skinner G
    Biochim Biophys Acta; 1990 Mar; 1038(1):52-9. PubMed ID: 2156572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric binding of the inhibitor di(adenosine-5') pentaphosphate (Ap5A) to adenylate kinase.
    Nageswara Rao BD; Cohn M
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5355-7. PubMed ID: 202953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.